Data spanning the past 90 days through January 09, 2026 reveals that DiaMedica Therapeutics's three principal insider shareholders consist of TenPercentOwner Jan Stahlberg (8.83Mn shares), TenPercentOwner Koch Thomas Von (8.38Mn shares), TenPercentOwner Richard Ii Jacinto (4.96Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jan Stahlberg | 8,825,742 | 08 Dec, 2025 | |
| Koch Thomas Von | 8,383,577 | 25 Jul, 2025 | |
| Richard Ii Jacinto | 4,958,823 | 25 Jul, 2025 | |
| David J. Wambeke | Chief Business Officer | 527,114 | 16 Nov, 2023 |
| Randall Michael Giuffre | 398,587 | 06 Jan, 2026 | |
| Richard D. Pilnik | 312,995 | 08 Apr, 2025 | |
| James T. Parsons | 97,949 | 06 Jan, 2026 | |
| Amy L. Burroughs | 73,288 | 03 Jan, 2023 | |
| Dietrich John Pauls | President And Ceo | 68,591 | 26 Jun, 2023 |
| Charles Pauling Semba | 47,963 | 06 Jan, 2026 | |
| Harry W Jr Alcorn | Svp And Clinical Operations | 43,981 | 15 Sep, 2021 |
| Scott Kellen | Cfo And Secretary | 32,290 | 26 Jun, 2023 |
| Richard Kuntz | 24,210 | 03 Jan, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Randall Michael Giuffre | Common Stock | A | 6,175 | $8.42 | 398,587 | D | A |
| 02 Jan, 2026 | James T. Parsons | Common Stock | A | 10,095 | $8.42 | 97,949 | D | A |
| 02 Jan, 2026 | Charles Pauling Semba | Common Stock | A | 3,355 | $8.42 | 47,963 | D | A |
| 25 Nov, 2025 | Jan Stahlberg | Common Shares | A | 73,099 | $8.57 | 8,825,742 | I | P |
| 25 Nov, 2025 | Jan Stahlberg | - | - | 8,825,742 | I | |||
| 24 Nov, 2025 | Jan Stahlberg | Common Shares | A | 40,253 | $7.89 | 8,752,643 | I | P |
| 24 Nov, 2025 | Jan Stahlberg | - | - | 8,752,643 | I | |||
| 21 Nov, 2025 | James T. Parsons | Common Stock | A | 12,000 | $2.20 | 87,854 | D | M |
| 21 Nov, 2025 | Jan Stahlberg | - | - | 8,712,390 | I | |||
| 21 Nov, 2025 | Jan Stahlberg | Common Shares | A | 208,872 | $7.41 | 8,712,390 | I | P |
| 20 Nov, 2025 | Jan Stahlberg | Common Shares | A | 128,426 | $7.41 | 8,503,518 | I | P |
| 20 Nov, 2025 | Jan Stahlberg | - | - | 8,503,518 | I | |||
| 19 Nov, 2025 | Jan Stahlberg | Common Shares | A | 240,352 | $7.21 | 8,375,092 | I | P |
| 19 Nov, 2025 | Jan Stahlberg | - | - | 8,375,092 | I | |||
| 18 Nov, 2025 | Jan Stahlberg | Common Shares | A | 182,882 | $6.75 | 8,134,740 | I | P |
| 18 Nov, 2025 | Jan Stahlberg | - | - | 8,134,740 | I | |||
| 17 Nov, 2025 | Jan Stahlberg | Common Shares | A | 187,393 | $6.52 | 7,951,858 | I | P |
| 17 Nov, 2025 | Jan Stahlberg | - | - | 7,951,858 | I | |||
| 27 Aug, 2025 | Jan Stahlberg | Common Shares | A | 50,772 | $6.00 | 7,764,465 | I | P |
| 26 Aug, 2025 | Jan Stahlberg | Common Shares | A | 59,648 | $6.00 | 7,713,693 | I | P |